Fennec Pharmaceuticals Inc (FENC) Annual Balance Sheets

Annual · GAAP · USD millions
Access FENC quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Fennec Pharmaceuticals Inc finances operations and invests in assets.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent36.79
Cash, Cash Equivalents Other36.79
Cash & Short-term Investments72.00
Accounts receivable23.22
Inventories1.57
Other Current Assets1.73
Prepaid Expense, Current AS3.74
Total Current Assets67.04
Long-term investments2.79
Tax Assets, Noncurrent0.06
Accumulated Amortization of Noncurrent Deferred Finance Costs AC0.00
Other Assets, Noncurrent3.51
Deferred Finance Costs Ownshare Lending Arrangement Issuance Costs Net-
Total Assets70.55
Liabilities
Accounts Payable, Current AC4.64
Accrued Liabilities, Current AC5.64
Other Liabilities, Current0.25
Total Current Liabilities10.52
Long-term debt0.00
Debt Instrument, Unamortized Discount0.00
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.03
Other liabilities, Noncurrent0.00
Contract With Customer Liability Current-
Accrued Paid In Kind Interest-
Operating Lease Liability Noncurrent-
Contract With Customer Liability Noncurrent24.56
Total Liabilities35.08
Stockholders' Equity
Common Stock Value189.91
Additional Paid In Capital Common Stock73.75
Retained Earnings / Accumulated Deficit-229.42
Accumulated Other Comprehensive Income1.24
Other Equity1.24
Common Stockholder's Equity35.47
Total Stockholder's Equity35.47
Liabilities & Stockholder's Equity70.55
4 historic quarters locked

Sign in to unlock the full Fennec Pharmaceuticals Inc balance sheet history.

About Fennec Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-036182

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.